Key facts
- Notable investors include InnoMed Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Junxinmed
- ·The full record, as it builds
Funding rounds
No funding rounds for Junxinmed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Junxinmed
Provider of a high-end medical service intended to advance precision oncology care and hospital management. The company offers remote radiotherapy planning, multidisciplinary case consultations, and centralized quality control systems, enabling specialized cancer centers and regional hospitals to deliver accurate treatment protocols and elevate clinical outcomes.
- Sector
- Healthcare
- HQ
- Foshan, China
- Founded
- 2022
- Website
- junxinmed.com/
- Ownership
- Privately Held (backing)
Junxinmed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Junxinmed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Junxinmed in its N-PORT filings yet. We sweep new filings monthly.